S. Poser

发表

Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies

J. Wiltfang, B. Mollenhauer, H. Kretzschmar, 2005, Dementia and Geriatric Cognitive Disorders.

Clinical diagnosis and differential diagnosis of CJD and vCJD

I. Zerr, S. Poser, 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid

O. Gefeller, I. Zerr, O. Windl, 1996, The Lancet.

CLINICAL DATA FROM 418 MS PATIENTS IN RELATION TO THE DIAGNOSIS. FIRST EXPERIENCES WITH AN OPTICAL MARK READER DOCUMENTATION SYSTEM

S. Poser, H. Hauptvogel, Harald Hauptvogel, 1973, Acta neurologica Scandinavica.

Increasing incidence of multiple sclerosis in South Lower Saxony, Germany.

S. Poser, D. Burckhardt, B. Stickel, 1989, Neuroepidemiology.

Isoform Pattern of 14‐3‐3 Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt‐Jakob Disease

J. Kornhuber, J. Wiltfang, H. Kretzschmar, 1999, Journal of neurochemistry.

Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies

J. Wiltfang, W. Schulz-Schaeffer, H. Kretzschmar, 2000, Neurology.

Epidemiology of MS

J. Kurtzke, S. Poser, 1991, Neurology.

[Therapy of epilepsy in children].

S. Poser, G. Ritter, 1973, Krankenpflege.

Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD)

A. Drzezga, I. Zerr, H. Tschampa, 2002, Journal of Neurology.

[Course of anxiety, depression, and quality of life in relatives of patients with Creutzfeldt-Jakob-Disease]

I. Zerr, S. Poser, C. Herrmann, 1999, Zeitschrift fur Psychosomatische Medizin und Psychotherapie.

Iatrogenic Creutzfeldt‐Jakob Disease with Florid Plaques

H. Kretzschmar, I. Zerr, O. Windl, 2003, Brain pathology.

Immunochemical determination of cellular prion proteinin plasma from healthy subjects and patients withsporadic CJD or other neurologic diseases

I. Zerr, S. Poser, H. Schwarz, 2001, Transfusion.

Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders

H. Kretzschmar, I. Zerr, S. Poser, 2001, Human Genetics.

C‐reactive protein and IL‐6: new marker proteins for the diagnosis of CJD in plasma?

I. Zerr, S. Poser, H. Schwarz, 2001, Transfusion.

S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

O. Gefeller, H. Kretzschmar, I. Zerr, 1997, Journal of Neurology.

The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosis

F. Weber, P. Rieckmann, S. Poser, 1996, Neurology.

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

J. Wiltfang, B. Mollenhauer, H. Kretzschmar, 2005, Dementia and geriatric cognitive disorders.

Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients

F. Weber, A. Bitsch, H. Tumani, 2002, Neuroscience Letters.

Increased Lipid Peroxidation in Cerebrospinal Fluid and Plasma from Patients with Creutzfeldt–Jakob Disease

I. Zerr, S. Arlt, C. Buhmann, 2002, Neurobiology of Disease.

Creutzfeldt–Jakob disease and oxidative stress

J. Kornhuber, J. Wiltfang, H. Kretzschmar, 2000, Acta neurologica Scandinavica.

Monocyte/macrophage differentiation in early multiple sclerosis lesions

Hans Lassmann, Wolfgang Brück, W. Brück, 1995, Annals of neurology.

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b

F. Weber, A. Bitsch, H. Tumani, 2002, Journal of Neuroimmunology.

Progress in Multiple Sclerosis Research

S. Poser, H. Bauer, G. Ritter, 1980, Springer Berlin Heidelberg.

Epidemiology and risk factors of transmissible spongiform encephalopathies in man.

I. Zerr, S. Poser, 2001, Contributions to microbiology.

Unaltered apoptotic behaviour of mononuclear cells from patients with sporadic Creutzfeldt-Jakob disease

H. Kretzschmar, L. Cepek, S. Poser, 2001, Journal of Neurology.

Elevated levels of serum S100 beta protein in scrapie hamsters.

M. Beekes, S. Poser, M. Otto, 1998, Journal of neurovirology.

Different binding pattern of antibodies to prion protein on lymphocytes from patients with sporadic Creutzfeldt–Jakob disease

J. Wiltfang, H. Kretzschmar, S. Arlt, 2003, Neuroscience Letters.

Follow-Up Investigations of Tau Protein and S-100B Levels in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease

J. Wiltfang, B. Mollenhauer, H. Kretzschmar, 2005, Dementia and Geriatric Cognitive Disorders.

Pregnancy, oral contraceptives and multiple sclerosis *

S. Poser, W. Poser, J. Wikström, 1979, Acta neurologica Scandinavica.

Interferon-β-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis

F. Weber, A. Bitsch, H. Tumani, 2003, Journal of Neurology.

Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier

S. Poser, J. Wikström, H. Bauer, 1977, Journal of Neurology.

Prognosis of multiple sclerosis. Results from an epidemiological area in Germany.

S. Poser, W. Poser, H. Bauer, 1982, Acta neurologica Scandinavica.

Phenotypic markers and functional characteristics of T lymphocyte clones from cerebrospinal fluid in multiple sclerosis

S. Poser, B. Fleischer, H. Kreth, 1985, Journal of Neuroimmunology.

[Indications for stereotaxic neurosurgery of patients with multiple sclerosis (author's transl)].

S. Poser, H. Orthner, H. Hauptvogel, 1975, Journal of neurology.

Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b

F. Weber, A. Bitsch, H. Tumani, 2004, Journal of Neurology.

Acute diffuse leukoencephalitis in HIV-1 infection.

S. Poser, W. Lüer, K. Felgenhauer, 1994, Journal of neurology, neurosurgery, and psychiatry.

Lack of evidence for involvement of known human retroviruses in multiple sclerosis

S. Poser, A. Karpas, Å. Sidén, 1986, Nature.

Impact of magnetic resonance imaging (MRI) on the epidemiology of MS

S. Poser, W. Lüer, B. Kitze, 1991, Acta neurologica Scandinavica.

[The occurrence of multiple sclerosis in Southern Lower Saxony: results of a 12-year field study (author's transl)].

S. Poser, J. Wikström, W. Firnhaber, 1977, Der Nervenarzt.

Discussion on Kurtzke’s: Clinical Trials in Multiple Sclerosis

S. Poser, 1986 .

Clinical Studies in Multiple Sclerosis

S. Poser, 1986 .

Chronic HIV encephalitis — I. cerebrospinal fluid diagnosis

S. Poser, H. Pohle, W. Lüer, 1988, Klinische Wochenschrift.

Chronic HIV encephalitis

S. Poser, W. Lüer, K. Felgenhauer, 1988, Journal of Neuroimmunology.

Temperature Controlled Chip Reactor for Rapid PCR

J. Köhler, S. Poser, G. Mayer, 1998 .

Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects

P Brown, B. Ghetti, A. Giese, 1999, Annals of neurology.

Multiple sclerosis: an ańalysis of 812 cases by means of electronic data processing.

S. Poser, 1979, Schriftenreihe Neurologie.

Cyclosporine versus azathioprine in the long‐term treatment of multiple sclerosis—results of the german multicenter study

W Fierz, J P Malin, U Patzold, 1988, Annals of neurology.

Oligodendrocytes in the early course of multiple sclerosis

W. Brück, H. Lassmann, S. Poser, 1994, Annals of neurology.

β‐amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

H. Hampel, J. Kornhuber, J. Wiltfang, 2003 .

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

H. Hampel, J. Kornhuber, J. Wiltfang, 2003, Annals of neurology.

Complement dependent cytotoxic antibody activity against measles virus in multiple sclerosis

S. Poser, J. Wikström, H. Bauer, 1977, Journal of Neurology.

Analysis of interleukin-4 receptor α chain variants in multiple sclerosis

F. Weber, P. Rieckmann, A. Bitsch, 2001, Journal of Neuroimmunology.

Genetic predisposition to multiple sclerosis as revealed by immunoprinting

H. Przuntek, J. Malin, F. Weber, 1997, Annals of neurology.

Prognostic indicators in multiple sclerosis

K. Lauer, S. Poser, W. Poser, 1986, Acta neurologica Scandinavica.

Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity

A. Broocks, P. Rieckmann, H. Tumani, 1995, Annals of neurology.

Acute demyelinating disease. Classification and non‐invasive diagnosis

J. Frahm, H. Bruhn, S. Poser, 1992, Acta neurologica Scandinavica.

Multiple sclerosis and gestation

S. Poser, W. Poser, Sigrid Poser, 1983, Neurology.

Prognosis of multiple sclerosis *

S. Poser, W. Poser, H. Bauer, 1982, Deutsche medizinische Wochenschrift.

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

J. Wiltfang, B. Mollenhauer, C. Trenkwalder, 2006, Dementia and Geriatric Cognitive Disorders.

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

P. Lewczuk, J. Wiltfang, B. Mollenhauer, 2004, Neuroscience Letters.

CSF Lactate Dehydrogenase Activity in Patients with Creutzfeldt-Jakob Disease Exceeds That in Other Dementias

H. Kretzschmar, L. Cepek, S. Poser, 2004, Dementia and Geriatric Cognitive Disorders.

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease

J. Wiltfang, B. Mollenhauer, H. Kretzschmar, 2002, Neurology.

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

O. Gefeller, A. Giese, H. Kretzschmar, 1998, BMJ.

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

J. Kornhuber, H. Kretzschmar, I. Zerr, 1997, Neuroscience Letters.

Occupational Performance of Patients with Multiple Sclerosis

S. Poser, R. Schipper, P. Denecke, 1985 .

Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease

O. Gefeller, H. Kretzschmar, I. Zerr, 1998, Annals of neurology.

[Recent developments in multiple sclerosis research (author's transl)].

S. Poser, 1979, Der Nervenarzt.

No evidence of Borna disease virus-specific antibodies in multiple sclerosis patients in Germany

P. Rieckmann, S. Poser, J. Richt, 1996, Journal of Neurology.

Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease

H. Kretzschmar, W. Schulz-Schaeffer, I. Zerr, 1999, Neuroscience Letters.

Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease

B. Steinhoff, H. Kretzschmar, W. Schulz-Schaeffer, 2004, Annals of neurology.

Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology.

B. Steinhoff, H. Kretzschmar, W. Schulz-Schaeffer, 2002, Brain : a journal of neurology.

Neurological Aspects of False Diagnosis and Failure to Diagnose Multiple Sclerosis

S. Poser, H. Orthner, H. Bauer, 1975 .

Current clinical diagnosis in Creutzfeldt‐Jakob disease: Identification of uncommon variants

B. Steinhoff, O. Gefeller, A. Giese, 2000, Annals of neurology.

Efficacy of flupirtine on cognitive function in patients with CJD

E. Irle, J. Wiltfang, H. Kretzschmar, 2004, Neurology.

Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis

F. Weber, A. Broocks, P. Rieckmann, 1996, Journal of Neuroimmunology.

Use of bromide electrodes for rapid screening of elevated bromide concentrations in biological fluids.

S. Poser, W. Poser, B. Müller-Oerlinghausen, 1974, Zeitschrift fur klinische Chemie und klinische Biochemie.

[Test strips for the detection of high bromide concentrations in body fluids].

H. Joost, S. Poser, W. Poser, 1974, Der Nervenarzt.

The German FFI Cases

A. Giese, H. Kretzschmar, W. Schulz-Schaeffer, 1998, Brain pathology.

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer’s disease

J. Wiltfang, B. Mollenhauer, H. Kretzschmar, 2005, Journal of Neural Transmission.

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients a with multinle sclerosis

A. Broocks, P. Rieckmann, H. Tumani, 1994, Neurology.

Optic neuritis as an initial symptom in multiple sclerosis

S. Poser, J. Wikström, G. Ritter, 1980, Acta neurologica Scandinavica.

Interferon beta‐1b modulates serum sVCAM‐1 levels in primary progressive multiple sclerosis

F. Weber, A. Bitsch, H. Tumani, 2004, Acta neurologica Scandinavica.

Mortality in patients with dependence on prescription drugs.

S. Poser, W. Poser, P. Eva-Condemarín, 1992, Drug and alcohol dependence.

MARKER PROTEINS FOR CJD IN PLASMA

I. Zerr, S. Poser, H. Schwarz, 2001 .

Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies

J. Wiltfang, B. Mollenhauer, J. Locascio, 2007, Neurodegenerative Diseases.

Effect of interferon β on human myelin basic protein–specific T-cell lines: Comparison of IFNβ-1a and IFNβ-1b

P. Rieckmann, S. Poser, T. Polak, 1999, Neurology.

Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis

F. Weber, P. Rieckmann, A. Bitsch, 1998, Annals of neurology.

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

A. Broocks, P. Rieckmann, H. Tumani, 1994, Neurology.

Kinetics of Measles Virus Antibodies in Multiple Sclerosis Patients in Correlation to the Clinical Course of the Disease

S. Poser, H. Bauer, E. Kuwert, 1980 .

[Abuse of and dependence on benzodiazepines].

S. Poser, W. Poser, 1986, Der Internist.

Age at onset, initial symptomatology and the course of multiple sclerosis

S. Poser, W. Poser, N. Raun, 1982, Acta neurologica Scandinavica.

The Effect of Ciclosporin versus Azathioprine on the Course of Multiple Sclerosis; Design of a Long-term Follow-up Study and Side Effects

L. Kappos, J. Malin, S. Poser, 1985 .

HLA-antigens and the prognosis of multiple sclerosis

S. Poser, H. Grosse-wilde, H. Bauer, 2004, Journal of Neurology.

Diagnostic problems during late course in Creutzfeldt-Jakob disease

B. Steinhoff, B. Mollenhauer, W. Schulz-Schaeffer, 2003, Journal of Neurology.

[Early retirement and occupational rehabilitation of patients with multiple sclerosis].

S. Poser, G. Hassink, U. Manegold, 1993, Die Rehabilitation.

Activity of multiple sclerosis during pregnancy and puerperium

S. Poser, W. Poser, MD Sigrid Poser, 1985, Annals of neurology.

Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis

L. Kappos, S. Poser, T. Heitzer, 2004, Neuroradiology.

Survival in multiple sclerosis.

J. Kurtzke, S. Poser, W. Poser, 1989, Journal of clinical epidemiology.

Early prognostic factors for disability in multiple sclerosis, a European multicenter study

K. Lauer, T. Riise, S. Poser, 1992, Acta neurologica Scandinavica.

Rehabilitation for patients with multiple sclerosis?

S. Poser, H. Bauer, G. Ritter, 2004, Journal of Neurology.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

K. Hess, A. Gass, L. Kappos, 2004, Journal of neurology.

Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system

S. Poser, H. Bauer, Wikström, 1979, Journal of the Neurological Sciences.

Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease

I. Zerr, S. Poser, C. Riedemann, 1998, Journal of neurology, neurosurgery, and psychiatry.

Thermoelectric radiation microsensors

T. Elbel, S. Poser, H. Fischer, 1994 .

Multiple sclerosis: what can and cannot be done.

S. Poser, W. Poser, 1980, British medical journal.

Chronic HIV encephalitis — II. clinical aspects

S. Poser, H. Pohle, W. Lüer, 1988, Klinische Wochenschrift.

Prognostic value of CSF IgG in monosymptomatic optic neuritis

S. Poser, W. Behrens-Baumann, H. Schipper, 1984 .

DO BENZODIAZEPINES CAUSE CEREBRAL ATROPHY?

S. Poser, W. Poser, A. Argyrakis, 1983, The Lancet.

Epidemiological aspects of multiple sclerosis: a comparative study of four centres in Europe.

K. Lauer, S. Poser, A. Prange, 1986, Neuroepidemiology.

Serological response of multiple sclerosis patients and controls to 6/94-parainfluenza virus

S. Poser, J. Wikström, H. Bauer, 1977, Journal of Neurology.

[Oral contraceptives--indications and neurological complications (author's transl)].

S. Poser, 1977, Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete.

A new variant of Creutzfeldt-Jakob disease in the UK

A. Hofman, A. Alpérovitch, S. Cousens, 1996, The Lancet.

[Toxic effects of drugs on the central nervous system].

S. Poser, W. Poser, 1983, Der Nervenarzt.

Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease

B. Steinhoff, H. Kretzschmar, W. Schulz-Schaeffer, 2001, Journal of neurology, neurosurgery, and psychiatry.

Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease

H. Budka, J. Laplanche, H. Bernheimer, 2000, Neurology.

Escalating immunotherapy of multiple sclerosis

A. Gass, L. Kappos, S. Schmidt, 2004, Journal of Neurology.

[Abuse of bromo-ureides and bromides. An acute addiction problem (author's transl)].

S. Poser, W. Poser, M. Echternkamp, 1974, Deutsche medizinische Wochenschrift.

Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada

A. Aguzzi, H. Budka, C. V. van Duijn, 2005, Neurology.

The use of recombinant antigens in ELISA procedures for the quantification of intrathecally produced HIV-1-specific antibodies.

S. Poser, J. Haas, W. Lüer, 1991, Journal of immunological methods.

MR imaging of Creutzfeldt-Jakob disease.

I. Zerr, S. Poser, S. Poser, 1996, Radiology.

Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease.

B. Steinhoff, H. Kretzschmar, H. Kretzschmar, 1996, Archives of neurology.

Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease

H. Kretzschmar, I. Zerr, S. Poser, 1995, The Lancet.

Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95

E. Granieri, A. Alpérovitch, I. Zerr, 1998, The Lancet.

Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

A. Aguzzi, H. Budka, C. V. van Duijn, 2004, Brain : a journal of neurology.

Sporadic Creutzfeldt–Jakob disease and surgery: A case–control study using community controls

C. V. van Duijn, A. Alpérovitch, I. Zerr, 2002, Neurology.

Molecular genetics of human prion diseases in Germany

A. Giese, H. Kretzschmar, W. Schulz-Schaeffer, 1999, Human Genetics.

Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

J. Kornhuber, J. Wiltfang, W. Schulz-Schaeffer, 2000, Neurology.

Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.

F. Weber, P. Rieckmann, A. Bitsch, 2001, Journal of Neuroimmunology.

Chip elements for fast thermocycling

Ulrich Dillner, Volker Baier, Johann Michael Köhler, 1997 .

Phenotypic variability in fatal familial insomnia (D178N-129M) genotype

A. Giese, W. Schulz-Schaeffer, H. Kretzschmar, 1998, Neurology.

Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene.

H. Kretzschmar, I. Zerr, S. Poser, 1995, Brain research. Molecular brain research.

Sporadic Creutzfeldt-Jakob disease

B. Mollenhauer, B. Meissner, H. Kretzschmar, 2004, Neurology.

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.

F. Weber, A. Bitsch, H. Tumani, 2003, Journal of Neurology.

Hashimoto's encephalitis as a diVerential diagnosis of Creutzfeldt-Jakob disease

B. Mollenhauer, I. Zerr, S. Poser, 1999 .

Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease.

I. Zerr, H. Tschampa, S. Poser, 2000, Archives of neurology.

How to improve the clinical diagnosis of Creutzfeldt-Jakob disease.

B. Steinhoff, B. Mollenhauer, W. Schulz-Schaeffer, 1999, Brain : a journal of neurology.

The Heidenhain variant of Creutzfeldt-Jakob disease.

B. Steinhoff, H. Kretzschmar, W. Schulz-Schaeffer, 1999, Archives of neurology.

Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease

H. Kretzschmar, I. Zerr, S. Poser, 1995, The Lancet.

Use of bromide electrodes for rapid screening of elevated bromide concentrations in biological fluids.

S. Poser, W. Poser, B. Müller-Oerlinghausen, 1974 .

Low power consumption thermal gas-flow sensor based on thermopiles of highly effective thermoelectric materials

J. Müller, Ulrich Dillner, Siegfried Poser, 1997 .